US Stock MarketDetailed Quotes
UNAM Unico American
- 0.020
- 0.0000.00%
15min DelayTrading May 24 16:00 ET
106.10KMarket Cap-8P/E (TTM)
0.000High0.000Low0Volume0.000Open0.020Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)5.30MShares1.37052wk High0.01P/B48.42KFloat Cap0.00252wk Low--Dividend TTM2.42MShs Float18.125Historical High--Div YieldTTM0.00%Amplitude0.002Historical Low--Avg Price1Lot Size
Unico American Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total investments | -44.49%47.52M | -42.23%56.23M | -25.40%71.23M | -10.50%78M | -10.50%78M | 1.63%85.6M | 10.94%97.33M | 10.53%95.48M | 0.76%87.15M | 0.76%87.15M |
| -Fixed maturity investments | -45.26%300K | -45.26%300K | -62.41%300K | -62.41%300K | -62.41%300K | -31.33%548K | -31.33%548K | 0.00%798K | 0.00%798K | 0.00%798K |
| -Equity investments | ---- | 4.04%3.71M | 26.60%4.03M | 50.40%4.13M | 50.40%4.13M | 136.42%3.68M | 579.51%3.57M | 595.67%3.18M | --2.75M | --2.75M |
| -Short term investments | -41.97%47.22M | -43.98%52.21M | -26.89%66.9M | -12.01%73.57M | -12.01%73.57M | -0.61%81.37M | 7.87%93.21M | 7.48%91.5M | -2.44%83.61M | -2.44%83.61M |
| Cash and cash equivalents | --12.46M | --11.55M | --8.6M | 454.81%15.24M | 454.81%15.24M | ---- | ---- | ---- | -52.47%2.75M | -52.47%2.75M |
| Restricted cash and cash equivalents | -94.42%881.51K | -46.22%1.01M | -88.81%869.53K | -68.44%381.94K | -68.44%381.94K | 176.76%15.79M | -59.81%1.88M | 47.32%7.77M | --1.21M | --1.21M |
| Receivables | -17.25%23.99M | 5.18%27.95M | 10.59%28.53M | 11.59%29.23M | 11.59%29.23M | 3.36%28.99M | 30.72%26.57M | 30.61%25.8M | 34.82%26.2M | 34.82%26.2M |
| -Accounts receivable | -17.25%23.99M | 5.18%27.95M | 10.59%28.53M | 13.21%28.7M | 13.21%28.7M | 3.36%28.99M | 30.72%26.57M | 30.61%25.8M | 44.12%25.35M | 44.12%25.35M |
| -Notes receivable | ---- | ---- | ---- | -62.90%755.69K | -62.90%755.69K | ---- | ---- | ---- | -33.04%2.04M | -33.04%2.04M |
| -Recievables adjustments allowances | ---- | ---- | ---- | 81.22%-223.96K | 81.22%-223.96K | ---- | ---- | ---- | 0.72%-1.19M | 0.72%-1.19M |
| Accrued investment income | -30.89%302.04K | -31.28%317.8K | -20.16%397.86K | -7.99%369.93K | -7.99%369.93K | -4.30%437.06K | 17.07%462.46K | -1.01%498.32K | 1.19%402.05K | 1.19%402.05K |
| Deferred policy acquisition costs | --0 | --0 | --0 | -71.83%986.81K | -71.83%986.81K | -15.57%3.06M | 4.34%3.83M | -3.26%3.57M | -3.21%3.5M | -3.21%3.5M |
| Net PPE | -28.91%1.61M | -19.83%1.78M | -11.99%1.96M | 5.70%2.15M | 5.70%2.15M | -77.97%2.26M | -78.26%2.23M | -78.21%2.23M | -80.07%2.04M | -80.07%2.04M |
| Assets of discontinued operations | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --8.34M | --8.34M |
| Other assets | 216.27%1.45M | 427.84%1.14M | 103.42%518.73K | 60.23%502.1K | 60.23%502.1K | 0.69%459.9K | -41.57%215.37K | -45.57%255K | -27.18%313.36K | -27.18%313.36K |
| Total assets | -35.42%88.21M | -24.55%99.98M | -17.33%112.11M | -3.81%126.87M | -3.81%126.87M | 2.87%136.59M | 1.15%132.52M | 3.99%135.6M | 1.22%131.9M | 1.22%131.9M |
| Liabilities | ||||||||||
| Policy holders liabilities reserve | -31.00%70M | -17.05%79.05M | -5.00%89.14M | 3.90%96.93M | 3.90%96.93M | 8.71%101.45M | 30.02%95.3M | 25.79%93.83M | 27.63%93.29M | 27.63%93.29M |
| Payables | ---- | ---- | ---- | 28.80%507.9K | 28.80%507.9K | ---- | ---- | ---- | -18.16%394.34K | -18.16%394.34K |
| -Accounts payable | ---- | ---- | ---- | 29.15%508.15K | 29.15%508.15K | ---- | ---- | ---- | -18.04%393.47K | -18.04%393.47K |
| -Other payable | ---- | ---- | ---- | -128.88%-251 | -128.88%-251 | ---- | ---- | ---- | -50.74%869 | -50.74%869 |
| Current accrued expenses | -89.85%296K | -83.88%365.23K | -75.61%1.34M | -94.51%53.45K | -94.51%53.45K | 23.30%2.92M | -16.73%2.27M | 164.54%5.51M | 94.15%973.5K | 94.15%973.5K |
| Non current deferred liabilities | ---- | ---- | ---- | -50.64%224.54K | -50.64%224.54K | ---- | ---- | ---- | -12.53%454.88K | -12.53%454.88K |
| Total deposits | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --380.85K | --380.85K |
| Employee benefits | ---- | ---- | ---- | -91.47%12.41K | -91.47%12.41K | ---- | ---- | ---- | 28.93%145.47K | 28.93%145.47K |
| Other liabilities | ---- | ---- | ---- | 19.50%1.47M | 19.50%1.47M | ---- | ---- | ---- | 138.92%1.23M | 138.92%1.23M |
| Total liabilities | -32.64%70.3M | -18.60%79.42M | -8.91%90.49M | 2.40%99.19M | 2.40%99.19M | 9.07%104.37M | 28.35%97.57M | 29.56%99.34M | 28.77%96.87M | 28.77%96.87M |
| Shareholders'equity | ||||||||||
| Share capital | 0.39%3.8M | 0.70%3.8M | 0.70%3.8M | 0.31%3.78M | 0.31%3.78M | 0.30%3.78M | -0.01%3.77M | -0.01%3.77M | -0.02%3.77M | -0.02%3.77M |
| -common stock | 0.39%3.8M | 0.70%3.8M | 0.70%3.8M | 0.31%3.78M | 0.31%3.78M | 0.30%3.78M | -0.01%3.77M | -0.01%3.77M | -0.02%3.77M | -0.02%3.77M |
| Retained earnings | -47.71%14.11M | -35.05%19.15M | -38.69%18.94M | -19.82%22.95M | -19.82%22.95M | -12.13%26.97M | -39.38%29.48M | -37.05%30.89M | -42.89%28.62M | -42.89%28.62M |
| Gains losses not affecting retained earnings | -99.46%7.95K | -240.86%-2.39M | -169.50%-1.11M | -64.20%944.05K | -64.20%944.05K | -43.90%1.47M | -34.45%1.69M | 81.70%1.6M | 122.96%2.64M | 122.96%2.64M |
| Total stockholders'equity | -44.42%17.91M | -41.17%20.56M | -40.38%21.62M | -20.99%27.68M | -20.99%27.68M | -13.11%32.23M | -36.45%34.95M | -32.50%36.27M | -36.40%35.03M | -36.40%35.03M |
| Total equity | -44.42%17.91M | -41.17%20.56M | -40.38%21.62M | -20.99%27.68M | -20.99%27.68M | -13.11%32.23M | -36.45%34.95M | -32.50%36.27M | -36.40%35.03M | -36.40%35.03M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg